<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url><loc>https://insightsemerge.com/press-releases/innogen-pharmaceuticals-enters-into-licensing-agreement-with-arcera-life-sciences-for</loc><news:news><news:publication><news:name>Insights Emerge</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T10:28:36.717Z</news:publication_date><news:title>Innogen Pharmaceuticals Enters into Licensing Agreement with Arcera Life Sciences for Efsubaglutide Alfa, Accelerating International Expansion</news:title></news:news></url>
<url><loc>https://insightsemerge.com/press-releases/telomir-pharmaceuticals-selects-linical-to-advance-fda-cleared-phase-12-clinical-trial-of</loc><news:news><news:publication><news:name>Insights Emerge</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T13:05:41.044Z</news:publication_date><news:title>Telomir Pharmaceuticals Selects Linical to Advance FDA-Cleared Phase 1/2 Clinical Trial of Telomir-Zn in Triple-Negative Breast Cancer</news:title></news:news></url>
</urlset>